The Latest Cardiac and Vascular News
July 26, 2021 Second-quarter highlights Group sales increased to EUR 4.2 billion, with 9% comparable sales growth Comparable order intake decreased 15%, with strong double-digit growth in the Diagnosis & Treatment businesses and a decline in the Connected Care businesses on the back of COVID-19-related 167% growth in Q2 2020 […]
Rouen and Rennes, France, July 7, 2021 – Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique […]
July 7, 2021 First patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and treatment in the angio suite) to the conventional workflow (diagnosis in the CT or MRI suite followed by treatment in […]
July 01, 2021 FDA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has potential to improve standard of care for structural heart disease and electrophysiology procedures Reduced need for general anesthesia accelerates workflows, increases efficiency, and broadens treatment options Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in […]
June 30, 2021 Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces costs Technique can be implemented on existing MRI scanners Validated clinical trial results on more than 100 patients with diverse cardiac pathologies […]
June 22, 2021 First patient enrolled in global randomized controlled trial with up to 3,200 participants at 100 sites comparing patient outcomes after percutaneous coronary intervention (PCI) procedures guided by iFR data co-registered on the angiogram (interventional X-ray image) versus the current standard of care, an angiogram alone One of the largest-ever […]
Results show that first-of-its-kind device has a sustained treatment effect and a positive impact on quality of life Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips […]
May 19, 2021 Intelligent system provides spectral data for all patients, including cardiac, pediatric, and bariatric Fast, always on, low-dose path to precision diagnosis delivers rich spectral results in a single scan, with no special protocols Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique portfolio of solutions that integrate imaging, devices, software, informatics and services at each point in a cardiac patient’s journey at EuroPCR 2021 (May 18-20). During the virtual […]
May 14, 2021 Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the integration of its Interventional Hemodynamic System and market-leading portable Patient Monitor IntelliVue X3, providing […]
